Central monoamine neurotransmitters affect blood glucose homeostasis.
Activation of central cholinergic, noradrenergic histaminergic, and se
rotonergic neurons rapidly increase hepatic glucose output via the sym
pathetic nervous system. Acute hyperglycemia is mediated by three dist
inct pathways: the action of epinephrine on the liver, the action of g
lucagon on the liver, and the direct innervation of the liver. The rel
ative contribution of these factors to hyperglycemia can be altered by
diet and the kinds of neurotransmitters evoked in the central nervous
system, but the magnitude of epinephrine secretion is closely related
to the magnitude of hyperglycemia. On the other hand, neuropharmacolo
gical stimulation of central cholinergic muscarinic receptors, histami
nergic H-1 receptors, and serotonergic 5-HT2 receptors increases hypot
halamic noradrenergic neuronal activity, which is associated with hype
rglycemia. In contrast, central GABA(A) receptors play an inhibitory r
ole in the regulation of hepatic glucose metabolism. Thus, central mon
oaminergic neurons could be linked together, and play a homeostatic ro
le in the regulation of hepatic glucose metabolism.